These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27177678)

  • 1. In Vivo (19)F-Magnetic Resonance Imaging of Adoptively Transferred NK Cells.
    Somanchi SS; Kennis BA; Gopalakrishnan V; Lee DA; Bankson JA
    Methods Mol Biol; 2016; 1441():317-32. PubMed ID: 27177678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive In Vivo Fluorescence Imaging of NK Cells in Preclinical Models of Adoptive Immunotherapy.
    Somanchi SS
    Methods Mol Biol; 2016; 1441():307-16. PubMed ID: 27177677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine-19 nuclear magnetic resonance of chimeric antigen receptor T cell biodistribution in murine cancer model.
    Chapelin F; Gao S; Okada H; Weber TG; Messer K; Ahrens ET
    Sci Rep; 2017 Dec; 7(1):17748. PubMed ID: 29255242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by 19F-Fluorine MRS/MRI.
    Gonzales C; Yoshihara HA; Dilek N; Leignadier J; Irving M; Mieville P; Helm L; Michielin O; Schwitter J
    PLoS One; 2016; 11(10):e0164557. PubMed ID: 27736925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells.
    Vahedi F; Nham T; Poznanski SM; Chew MV; Shenouda MM; Lee D; Ashkar AA
    Sci Rep; 2017 Sep; 7(1):12083. PubMed ID: 28935883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging.
    Meier R; Golovko D; Tavri S; Henning TD; Knopp C; Piontek G; Rudelius M; Heinrich P; Wels WS; Daldrup-Link H
    Magn Reson Med; 2011 Mar; 65(3):756-63. PubMed ID: 20928869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI.
    Kennis BA; Michel KA; Brugmann WB; Laureano A; Tao RH; Somanchi SS; Einstein SA; Bravo-Alegria JB; Maegawa S; Wahba A; Kiany S; Gordon N; Silla L; Schellingerhout D; Khatua S; Zaky W; Sandberg D; Cooper L; Lee DA; Bankson JA; Gopalakrishnan V
    J Neurooncol; 2019 May; 142(3):395-407. PubMed ID: 30788681
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Sato N; Stringaris K; Davidson-Moncada JK; Reger R; Adler SS; Dunbar C; Choyke PL; Childs RW
    Clin Cancer Res; 2020 Jun; 26(11):2573-2581. PubMed ID: 32034075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
    Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL
    Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
    Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
    Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cytokine Cocktail Augments the Efficacy of Adoptive NK-92 Cell Therapy Against Mouse Xenografts of Human Cancer.
    Samara P; Skopeliti M; Tsiatas ML; Georgaki S; Gouloumis C; Voelter W; Dimopoulos AM; Bamias A; Tsitsilonis OE
    Anticancer Res; 2016 Jul; 36(7):3373-82. PubMed ID: 27354596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-guided interventional natural killer cell delivery for liver tumor treatment.
    Su Z; Wang X; Zheng L; Lyu T; Figini M; Wang B; Procissi D; Shangguan J; Sun C; Pan L; Qin L; Zhang B; Velichko Y; Salem R; Yaghmai V; Larson AC; Zhang Z
    Cancer Med; 2018 May; 7(5):1860-1869. PubMed ID: 29601672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of recombinant human prolactin in human adenocarcinoma-bearing SCID mice with human NK cell xenograft.
    Zhang J; Sun R; Wei H; Tian Z
    Int Immunopharmacol; 2005 Feb; 5(2):417-25. PubMed ID: 15652770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.
    Zhang C; Burger MC; Jennewein L; Genßler S; Schönfeld K; Zeiner P; Hattingen E; Harter PN; Mittelbronn M; Tonn T; Steinbach JP; Wels WS
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26640245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and viability of murine NK cells in vivo in a lymphoma model using fluorine-19 MRI.
    Lechuga LM; Forsberg MH; Walker KL; Ludwig KD; Capitini CM; Fain SB
    NMR Biomed; 2021 Dec; 34(12):e4600. PubMed ID: 34409665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells.
    Cui F; Ji J; Lv H; Qu D; Yu C; Yang Y; Xu Y
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S162-8. PubMed ID: 24516054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.
    Shi L; Lin H; Li G; Sun Y; Shen J; Xu J; Lin C; Yeh S; Cai X; Chang C
    Cancer Lett; 2016 Apr; 373(1):45-56. PubMed ID: 26805759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
    Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
    Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.